Young age a predictor of weak reactivity in a rapid antibody test in infants infected with HIV

Leana Maree1, Gert U van Zyl, Shelley L Lotter

  • 1Division of Medical Virology, Department of Pathology, National Health Laboratory Service, University of Stellenbosch, Cape Town, South Africa. leana@sun.ac.za

Insights

Rapid HIV antibody tests show high false-negative rates in infants due to young age, not other factors. Caution is advised when using adult-validated rapid assays for infant HIV diagnosis.

Area of Science:

  • Immunology
  • Virology
  • Pediatric Infectious Diseases

Background:

  • Resource-constrained settings often rely on rapid antibody tests for infant HIV screening.
  • Previous studies indicate a high false-negative rate of rapid HIV assays in infants.
  • The Capillus HIV-1/HIV-2 test is a commonly used rapid antibody assay.

Purpose of the Study:

  • To identify predictors of low or negative antibody reactivity in infants using the Capillus HIV-1/HIV-2 assay.
  • To investigate factors such as CD4 count, HIV-1 viral load, and antigen-specific reactivity.
  • To determine if age is a significant factor in assay performance.

Main Methods:

  • Analysis of CD4 (+) count and percentage.
  • Measurement of HIV-1 viral load.
  • Assessment of antigen-specific reactivity.
  • Exploration of age as a predictor of assay results.

Main Results:

  • Young age was the only significant predictor of low antibody reactivity.
  • This age-related phenomenon was specific to HIV antibody response.
  • No similar age association was observed for antibody reactivity to tetanus toxoid.

Conclusions:

  • Rapid HIV antibody assays validated in adults may yield high false-negative rates in young infants.
  • Age is a critical factor influencing the reliability of rapid HIV testing in pediatric populations.
  • Clinical use of these assays in infants requires extreme caution and consideration of potential age-related limitations.